PNV has been killed by ASX200 removal and a wider bio-tech sell down:
I expect a bounce to $2 by year end on positive free cash flow and 50%+ growing revenues and the mkt selling pressures subsided. $3+ by June 2023 because it will be back in the ASX200, a rising stock at the tail end of the ASX200 mkt caps where stocks remain mostly on their knees amidst a stuttering global economy and aimless central banks all over the place with inflation up and down and money markets in strife.
30th June 2023 Share Price Prediction, page-11
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
0.020(0.78%) |
Mkt cap ! $1.780B | |||
| Open | High | Low | Value | Volume |
| $2.61 | $2.63 | $2.56 | $2.465M | 952.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10700 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 24502 | 5 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |